24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trialHilkka Soininen, Noel Ellison, Suzanne Hendrix et al.|The Lancet Neurology|2017Cited by 244
Designing drug trials for Alzheimer's disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task ForceBruno Vellas, María C. Carrillo, Cristina Sampaio et al.|Alzheimer s & Dementia|2013Cited by 145